Chrisandra Shufelt

Psychosocial stress in women with functional hypothalamic amenorrhea and potential implications for cardiovascular disease risk

Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?

Age at Menopause, Leukocyte Telomere Length, and Coronary Artery Disease in Postmenopausal Women

Functional Hypothalamic Amenorrhea and Preclinical Cardiovascular Disease

Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women

Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement

Gender-Related Differences in Chest Pain Syndromes in the Frontiers in CV Medicine Special Issue: Sex & Gender in CV Medicine

Prior Oral Contraceptive Use and Longer Term Mortality Outcomes in Women with Suspected Ischemic Heart Disease

Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation)

Ambulatory and silent myocardial ischemia in women with coronary microvascular dysfunction: Results from the Cardiac Autonomic Nervous System study (CANS)

Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute‐Sponsored Women's Ischemia Syndrome Evaluation

A Machine Learning Approach to Classifying Self-Reported Health Status in a Cohort of Patients With Heart Disease Using Activity Tracker Data

Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease

Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease

Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study

Mental stress peripheral vascular reactivity is elevated in women with coronary vascular dysfunction: Results from the NHLBI-sponsored Cardiac Autonomic Nervous System (CANS) study

Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve

Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: An ancillary study of the National Heart, Lung, and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation

Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women

Safety of Coronary Reactivity Testing in Women With No Obstructive Coronary Artery Disease

Maternal Recall of Hypertensive Disorders in Pregnancy: A Systematic Review